Cover Image
市場調查報告書

全球血糖監測系統市場

Glucose Monitoring Devices

出版商 Global Industry Analysts, Inc. 商品編碼 225270
出版日期 內容資訊 英文 417 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球血糖監測系統市場 Glucose Monitoring Devices
出版日期: 2017年10月01日 內容資訊: 英文 417 Pages
簡介

本報告提供全球血糖監測系統 (BGM設備) 市場相關調查分析,提供您包含各產品區隔,地區 (美國,加拿大,日本,歐洲,亞太地區,南美等)之市場實際成果與預測,主要企業簡介等系統性資訊。

第1章 簡介,調查手法,產品定義

第2章 摘要整理

  • 產業概要
    • BGM設備
    • 全球糖尿病的盛行率
    • 全球BGM市場
    • 未來成長產品革新和推動進步
    • BGM產品的需求
    • 不景氣和前途
  • 競爭
    • 全球市場的前4大
    • 現場製藥公司的競爭
    • 低價格高品質的產品
    • 配合地區性需求
    • 準確度的容許範圍
  • 市場趨勢·問題點·推動因素
    • 全球糖尿病的盛行率之流行本質
    • 青年人的第一型·第二型糖尿病發病率的上升
    • 高齡化人口導致的糖尿病盛行率
    • 政府配合措施的增加
    • 血糖自我檢測(SMBG)
    • 遙控BGM的重要性劇增
    • 血糖值測試紙
    • 準確度的影響因素
    • 發展中國家的發病率和未診斷人口的增加
  • 技術革新和進步
    • 持續性血糖監測系統 (CGM)
    • CGM市場
    • 競爭情形
    • 有前途的市場
    • 主要課題
  • 糖尿病和BGM設備:概要
    • 所謂糖尿病
    • BGM
    • BGM設備
  • 產品革新/銷售
  • 近來產業活動
  • 全球主要企業
    • Abbott Diabetes Care, Inc. (美國)
    • AgaMatrix, Inc. (美國)
    • 電弧花環 (日本)
    • Arkray USA, Inc. (美國)
    • Bayer Healthcare (美國)
    • Bionime Corp. (台灣)
    • B. Braun Melsungen AG (德國)
    • DexCom, Inc. (美國)
    • LifeScan, Inc. (美國)
    • Medtronic (美國)
    • Nipro Diagnostics, Inc. (美國)
    • Nova Biomedical Corporation (美國)
    • Roche Diagnostics Corp. (美國)
    • Terumo Europe NV (比利時)
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第4章 競爭情形

  • 競爭企業簡介:83公司 (若包含產業部/子公司的話有97家公司)
    • 美國
    • 加拿大
    • 日本
    • 歐洲
    • 亞太地區 (日本以外)
    • 南美
    • 中東

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-3420

This report analyzes the worldwide markets for Glucose Monitoring Devices in US$ by the following Product Segments: Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, & Lancets), and Continuous Glucose Monitoring (CGM). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 77 companies including many key and niche players such as -

Abbott Diabetes Care, Inc.
ACON Laboratories, Inc.
AgaMatrix, Inc.
Alive Technologies Pty. Ltd.
Apex Biotechnology Corp.
ARKRAY, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions and Scope of Study

  • Self Glucose Monitoring (SGM)
    • Blood Glucose Strips
    • Blood Glucose Meters
    • Lancets
  • Continuous Glucose Monitoring (CGM)

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Glucose Monitoring Devices: Enabling Easier and Efficient Monitoring of the Global Diabetes Epidemic
  • Growth Drivers in a Nutshell
  • Glucose Monitoring Undergoes Notable Transformation over the Years: An Evolutionary Scan
  • Evolution of Diabetes Testing over the Years with Key Features in Each Period
  • Diabetes Incidence Reaching Epidemic Proportions Worldwide: Foundation for Market Growth
    • Table 1: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart)
    • Table 2: Global Prevalence (%) of Diabetes in Adults (20-79) by Region: 2015 & 2040 (includes corresponding Graph/Chart)
    • Table 3: Global Prevalence of Diabetes by Gender (2015 & 2040): Number of Adults Diagnosed with Diabetes (in Million) for Men and Women (includes corresponding Graph/Chart)
    • Table 4: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender: 2015 (includes corresponding Graph/Chart)
    • Table 5: Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (In Million) (includes corresponding Graph/Chart)
    • Table 6: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart)
  • Diabetes: One of the Leading Causes of Death Globally
    • Table 7: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region (includes corresponding Graph/Chart)
  • Diabetes Incidence and Prevalence by Region/Country
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
  • Asia-Pacific
    • Southeast Asian Region
    • Western Pacific Region
  • South & Central America
  • Africa
  • Global Market Outlook
  • Developed Countries are Dominant Markets, while Developing Countries Spearhead Market Growth
    • China: A High Potential Market for Glucose Monitoring Devices
    • Rising Diabetic Populace Spurs Growth in the Indian Market
    • Table 8: Global Glucose Monitoring Devices Market - Geographic Regions Ranked by CAGR (Value) for 2016-2024: China, India, Russia, UK, Germany, Japan, France, Canada, Italy, Spain, and USA (includes corresponding Graph/Chart)

2. COMPETITION

  • The 'Big Four' Dominate the Global Self Glucose Monitoring (SGM) Market
    • Table 9: Leading Players in the Global Blood Glucose Monitoring Devices Market (2017E): Percentage Market Share Breakdown for Abbott, Ascensia/ Panasonic, LifeScan/J&J, Roche, and Others (includes corresponding Graph/Chart)
  • Major Pharma Players Dominate Blood Glucose Monitoring Market
  • Innovations in BGM Devices Spearheaded by Startups
  • Competition with Local Pharma Companies Intensifies in Regional Markets
  • Quality Products at Low Prices: Mantra for Success in the Marketplace
  • After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move
  • Dexcom and Medtronic Dominates the Global CGM Devices Market
    • Table 10: Leading Continuous Glucose Monitoring (CGM) Companies Worldwide (2017E): Percentage Breakdown of Value Sales for Abbott, Dexcom, Medtronic, and Others (includes corresponding Graph/Chart)

3. MARKET TRENDS, ISSUES AND DRIVERS

  • Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose Monitors Drive Healthy Market Growth
  • Select Disruptive Glucose Monitors Promising Reduced Pain, Lesser Data Load, and Zero Worries
  • Innovative Smart Glucometers for Sugar Monitoring
    • iHealth Align
    • iHealth Smart
    • iBGStar
    • OneTouch Verio Sync
    • Dario Smart Glucose Meter
    • Dexcom G5 CGM System
  • Need for Real-Time Glucose Sensing and Monitoring Drive Strong Demand for Minimally-Invasive CGM Devices
  • Myriad Benefits of CGMs
  • CGM Market Gradually Breaks through Barriers to Adoption
    • Table 11: Penetration Rate (%) of CGM Devices in Type 1 and Type 2 Diabetes Market in the United States: 2013 through 2020 (includes corresponding Graph/Chart)
  • Intensive Care Units: A Highly Promising Market for CGMs
  • Key Challenges Hampering Widespread Adoption of CGM Systems
  • Despite Competition from CGM Systems, SGM Devices Continue to Dominate Sales
  • Blood Glucose Test Strips: The Largest Segment
  • Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
  • Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
    • Table 12: Global Blood Glucose Monitoring Devices Market by Application Segment (2017E): Percentage Breakdown of Demand for Hospitals & Labs, Households, and Physician Clinics (includes corresponding Graph/Chart)
  • Key Trends in the Glucose Meter/Monitoring Systems
  • Smartphone Penetration Favors SMBG Market
    • Table 13: Global Smartphone Adoption Rate and Connections (2013-2020) (includes corresponding Graph/Chart)
  • Barriers to Adoption of New Technology in BGM Products
  • Accuracy Issues Plague Blood Glucose Meters Market
  • Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
  • Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
    • Table 14: Number of Undiagnosed Individuals (20-79 Years in Million) Living with Diabetes and Proportion (%) Worldwide by Region: 2015 (includes corresponding Graph/Chart)
  • Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
  • Increased Vulnerability of Diabetics to Various Health Complications Drives the Need for Timely Glucose Monitoring
  • Heart Disease
  • Stroke
  • High Blood Pressure
  • Blindness
  • Kidney Disease
  • Nerve Disease
  • Amputations
  • Dental Disease
  • Pregnancy
  • Microvascular Complications (Small Blood Vessel Damage)
    • Retinopathy
    • Diabetic Neuropathy
    • Nephropathy
  • Macrovascular Complications (Large Blood Vessel Damage)
    • Cardiac Problems
    • Hypertension (High Blood Pressure)
  • Infections
  • Impotence
  • Pregnancy Complications
  • Other Complications Resulting from Diabetes
    • Obesity
    • Obsessive Compulsive Disorder
    • Foot Ulcers
    • Dementia
    • Hypoglycemia
    • Diabetic Ketoacidosis
  • Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
  • Higher Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
  • Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
    • Table 15: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 16: Global Population Statistics for the 65+ Age Group (2016) (includes corresponding Graph/Chart)
    • Table 17: Life Expectancy for Select Countries in Number of Years: 2016 (includes corresponding Graph/Chart)
  • Increasing Healthcare Expenditure Boosts Demand for SGM and CGM Devices
    • Table 18: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
    • Table 19: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart)
  • Expenditure on Diabetes Management
    • Table 20: Global Prevalence of Diabetes and Expenditure on its Management by Region (2015 & 2040P): Number of People Diagnosed with Diabetes in the Age Group 20-79 Years (Billions) and Expenditure on Management of Diabetes and its Complications (in US$ Billions) (includes corresponding Graph/Chart)
    • Table 21: Leading Countries by Health Expenditure on Diabetes (2015 & 2040) (in US$ Billion) (includes corresponding Graph/Chart)
    • Table 22: Expenditure on Diabetes in Adult (20-79) as % of Total Healthcare Spending by Region (2015) (includes corresponding Graph/Chart)
    • Table 23: Health Expenditure on Diabetes by Region: Average Diabetes-Related Spending per Person with Diabetes in US$ for 2015 (includes corresponding Graph/Chart)
    • Table 24: Health Expenditure on Diabetes (2015): Average Diabetes-Related Spending per Person with Diabetes (US$) in Select Countries (includes corresponding Graph/Chart)
  • Increasing Obesity Levels Underpins Market Growth
    • Table 25: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart)
    • Table 26: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart)

4. INNOVATIONS & ADVANCEMENTS

  • K'Track: Discreet and Painless Glucose- Monitoring Wearable
  • The Sugar iQ App Provide Predictive Diabetes Care
  • DIABNEXT(r) CLIPSULIN(r): World's First A.I Tool for Diabetes
  • e-mosquito CGM Device
  • FreeStyle Libre Flash Glucose Monitoring System
  • MyDario Mobile Data Management Platform
  • The New Handheld RL-BGM Device
  • TOUCH TG
  • Pocket-Sized Gadgets
  • Digital Contact Lenses
  • Gamification
  • Leveraging Big Data
  • Digital Tattoos
  • OneTouch(r) Verio Flex(r) Monitoring System
  • Artificial Pancreas System (APS): The Next Big Thing in Glucose Monitoring
  • The First-of-its-Kind Artificial Pancreas by Medtronic
  • Non-invasive, Acetone Detecting Breathalyzer for Glucose Testing
  • Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
  • EMG 1000: Needle-free Device for Glucose Monitoring
  • Glucase: Smartphone Case with Glucose Testing Kit
  • Painless Diabetes Monitoring Using NFC Technology
  • GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
  • ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
  • NoStrip(tm) Technology: Eliminating Need for Individual Test Strips
  • Other Innovative and Advanced Glucose Monitoring Systems
  • GlucoTrack(r)
  • A2I
  • Omnipod Horizon
  • V-Go
  • sugarBEAT
  • G5 Integrated Vibe Insulin Pump and CGM System
  • FreeStyle Libre and FreeStyle Libre Pro
  • Contour Next One and Contour Next Link
  • Bewell Connects
  • Biosensor-based Monitor called Lumee
  • Touchscreen Receiver/Android App
  • OneTouch Via
  • MiniMed 670G/Enlite 3 with Hybrid Closed Loop
  • Dexcom G5 Mobile CGM with Bluetooth
  • Dario-Smart Meter from LabStyle
  • Notable Early-stage Investigative Glucose Monitoring Devices

5. PRODUCT OVERVIEW

  • What is Diabetes?
  • Types of Diabetes
    • Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
    • Type II Diabetes: Non-Insulin Dependent Diabetes Mellitus (NIDDM)
      • NIDDM: Higher Risk of Cardiovascular Disease
    • Gestational Diabetes
    • Impaired Fasting Glycaemia (IFG) & Impaired Glucose Tolerance (IGT)
  • Self Glucose Monitoring (SGM) Devices
    • Blood Glucose Meters
      • Measurement Units
    • Blood Glucose Strips
    • Lancets
  • Continuous Glucose Monitoring (CGM) Systems
    • Operation of a Continuous Glucose Monitor (CGM)

6. PRODUCT INNOVATIONS/INTRODUCTIONS

  • ARKRAY Releases PocketChem VC PV-1350on Reducing Substances Meter
  • ARKRAY Releases BG Sensor
  • The U.S. Food and Drug Administration Approves Abbott' Glucose Monitoring Device
  • ARKRAY Releases Glycohemoglobin Analyzer ADAMS A1c HA-8190V
  • Intel Releases New Software Application Platform, IntelHAP
  • ARKRAY Releases GLUCOCARD W Blood Glucose Meter
  • Abbott's FreeStyle Libre Pro System Receives FDA Approval
  • Roche Launches Accu-Chek Guide(r) System
  • Ascensia Launches CONTOUR(r)NEXT LINK 2.4 Blood Glucose Monitoring System (BGMS)
  • ACON Laboratories Launches On Call(r) Pro Blood Glucose Meter
  • LifeScan Introduces OneTouch Verio Flex(tm)

7. RECENT INDUSTRY ACTIVITY

  • AgaMatrix Inc. Enters into a $32 Million Senior Term Loan Facility with Prospect
  • Fitbit Partners with Dexcom
  • Abbott Enters into Collaboration with Bigfoot Biomedical
  • Roche Acquires mySugr
  • Abbott Obtains the Health Canada License for FreeStyle(r) Libre Flash Glucose Monitoring System
  • Roche Signs a Partnership Agreement with Medtronic
  • TGA Approves for Abbott's FreeStyle(r) Libre System
  • Glooko and Diasend Enter into Merger
  • BioTelemetry Acquires Telcare Medical Supply
  • Mitsui to Acquire Shares in Panasonic Healthcare Holdings
  • ARKRAY Collaborates with LG Life Sciences Ltd.
  • Ascensia Diabetes Care Renews Global Alliance with Medtronic
  • Senseonics Signs Distribution Agreement with Roche
  • Dexcom G5(r) Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch
  • Cellnovo Signs a Commercial Agreement with Roche
  • Nemaura' sugarBEAT(r) Receives Notification of CE Approval
  • Tekcapital PLC Acquires the License for the Measurement of Glucose in Saliva
  • Abbott Obtains CE Mark for the FreeStyle Libre System
  • Nova Biomedical's StatStrip Glucose Xpress 2 Receives FDA Clearance
  • Sinocare Acquires Nipro Diagnostics Inc.
  • LabStyle's Dario System Receives FDA Clearance
  • Panasonic Healthcare Acquires the Bayer Diabetes Care Business

8. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Diabetes Care, Inc. (USA)
  • ACON Laboratories, Inc. (USA)
  • AgaMatrix, Inc. (USA)
  • Alive Technologies Pty. Ltd. (Australia)
  • Apex Biotechnology Corp. (Taiwan)
  • ARKRAY, Inc. (Japan)
  • Arkray USA, Inc. (USA)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • B. Braun Melsungen AG (Germany)
  • Beurer GmbH (Germany)
  • BIONIME Corporation (Taiwan)
  • Dexcom, Inc. (USA)
  • Entra Health Systems LLC (USA)
  • GlySens Incorporated (USA)
  • LifeScan, Inc. (USA)
  • Medtronic plc (Ireland)
  • Medtronic MiniMed, Inc. (USA)
  • Nova Biomedical Corporation (USA)
  • Omron Healthcare Co., Ltd. (Japan)
  • Roche Diagnostics (Switzerland)
  • Sanofi S.A. (France)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Senseonics Holdings, Inc. (USA)
  • Taidoc Technology Corporation (Taiwan)
  • Terumo Corporation (Japan)
  • Trividia Health, Inc. (USA)
  • Ypsomed Holding AG (Switzerland)

9. GLOBAL MARKET PERSPECTIVE

    • Table 27: World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for Glucose Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
  • Glucose Monitoring Devices by Product Group/Segment
    • Table 30: World Recent Past, Current & Future Analysis for Self Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for Self Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for Self Glucose Monitoring by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 33: World Recent Past, Current & Future Analysis for Self Glucose Monitoring by Product Segment - Blood Glucose Strips, Blood Glucose Meters, and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 34: World Historic Review for Self Glucose Monitoring by Product Segment - Blood Glucose Strips, Blood Glucose Meters, and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 35: World 14-Year Perspective for Self Glucose Monitoring by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters, and Lancets Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 36: World Recent Past, Current & Future Analysis for Blood Glucose Strips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 37: World Historic Review for Blood Glucose Strips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 38: World 14-Year Perspective for Blood Glucose Strips by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 39: World Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 40: World Historic Review for Blood Glucose Meters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 41: World 14-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 42: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 43: World Historic Review for Lancets by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 44: World 14-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 45: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 46: World Historic Review for Continuous Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 47: World 14-Year Perspective for Continuous Glucose Monitoring by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • The US: The Largest Glucose Monitoring Devices Market Worldwide
    • Table 48: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 49: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s)
    • Growth Drivers in a Nutshell
    • Aging Population: A Weighty Growth Factor
    • Table 50: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart)
    • Table 51: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart)
    • Table 52: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 53: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Economic Burden of Diabetes
    • Table 54: Health Expenditure (in US$ Billion) on Diabetes in the US: 2015 & 2040 (includes corresponding Graph/Chart)
    • Healthcare Reform Legislation: Impact on Glucose Monitoring Devices
    • Wearable and Non-Invasive Glucose Monitoring Devices Favored
    • Innovations in BGM Devices: The Key Challenges Faced by Developers
    • Emerging "Grey Market" for Testing Strips
    • Clinical Study Raises Doubts over Utility of Self Blood Glucose Monitoring
    • Regulatory Landscape
      • FDA Guidance for Blood Glucose Meters
      • FDA's Final Recommendations for New Blood Glucose Monitoring Devices
      • FDA's Proposal to Improve Blood Glucose Meter Accuracy in Critical Care Units Gathers Criticism
      • Regulations on Lancet Needles to be made More Stringent by FDA
      • TGC Protocols: A Key Driver for Point of Care BGM Market
    • Competitive Landscape
      • CGM Devices Marketplace: Highly Consolidated
    • Table 55: Leading Companies in the US CGM Market (2016 & 2020P): Percentage Share Breakdown of Revenue for Abbott, DexCom, Medtronic, and Others (includes corresponding Graph/Chart)
      • Companies Focus on Research for Better Glucose Monitoring
      • Drugstores Benefit from the Diabetic Care Category
      • Integrated Products: An Upcoming Trend
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 56: US Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 57: US Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 58: US 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Diabetes Statistics and Aging Population in Canada: Opportunity Indicators for Glucose Monitoring Devices
    • Table 59: Diabetes Statistics in Canada (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s)
    • Table 60: Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart)
    • Table 61: Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart)
    • Table 62: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Product Launch
  • B. Market Analytics
    • Table 63: Canadian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 64: Canadian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 65: Canadian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Rapidly Growing Aging Population and their Vulnerability to Diabetes Sustains Market Demand
    • Table 66: Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Trends Influencing Glucose Monitoring Market Summarized
    • Table 67: Diabetes Statistics in Japan (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Product Launch
    • Strategic Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 68: Japanese Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 69: Japanese Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 70: Japanese 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Healthy Growth Projected for the European Glucose Monitoring Devices Market
    • Diabetes Statistics in Europe
    • Table 71: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 72: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Reimbursement Scenario
  • B. Market Analytics
    • Table 73: European Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 74: European Historic Review for Glucose Monitoring Devices by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 75: European 14-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 76: European Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 77: European Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 78: European 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Diabetes & Aging Statistics: Opportunity Indicators for the French Market
    • Table 79: Diabetes Statistics in France (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Table 80: Aging Population in France (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Strategic Corporate Development
    • Sanofi S.A. - A Major France-Based Company
  • B. Market Analytics
    • Table 81: French Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 82: French Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 83: French 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Diabetes & Aging Statistics: Opportunity Indicators for the German Market
    • Table 84: Diabetes Statistics in Germany (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Table 85: Aging Population in Germany (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Select Key Players
  • B. Market Analytics
    • Table 86: German Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 87: German Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 88: German 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Diabetes & Aging Statistics: Opportunity Indicators for the Italian Market
    • Table 89: Diabetes Statistics in Italy (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Table 90: Aging Population in Italy (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 91: Italian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 92: Italian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 93: Italian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • The United Kingdom: One of the Leading Spenders on Diabetes Related Healthcare
    • Table 94: Diabetes Statistics in United Kingdom (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Table 95: Aging Population in the United Kingdom (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
      • Rising Obesity Cases - Increased Risk of Diabetes
      • Type 1 Diabetes in Children
    • Table 96: Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart)
    • NHS England Launches Action for Diabetes Plan
    • NHS Guidelines for Lancets, Testing Strips, and Meters for Blood Glucose Testing
    • Self-Monitoring Blood Glucose Meters Gain Popularity
    • NICE Recommendations for Self-Monitoring Blood Glucose (SMBG)
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 97: UK Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 98: UK Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 99: UK 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Spain: Diabetes & Aging Statistics
    • Table 100: Diabetes Statistics in Spain (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Table 101: Aging Population in Spain (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 102: Spanish Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 103: Spanish Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 104: Spanish 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Large Proportion of Undiagnosed Population Provides Market Growth Opportunities
    • Diabetes & Aging Statistics
    • Table 105: Diabetes Statistics in Russia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Table 106: Aging Population in Russia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 107: Russian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 108: Russian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 109: Russian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 110: Rest of Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 111: Rest of Europe Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 112: Rest of Europe 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • High Risk Population and Underpenetrated Nature of the Market Offers Huge Growth Opportunities
    • Table 113: Global Glucose Monitoring Devices Market - Geographic Regions Ranked by CAGR (Value) for 2016-2024: China, India, Russia, UK, Germany, Japan, France, Canada, Italy, Spain, and USA (includes corresponding Graph/Chart)
    • Table 114: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 115: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 116: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 117: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Role of Healthcare Societies and Associations
      • India
      • Bangladesh
      • Western Pacific Declaration on Diabetes
    • Public and Private Sector Diabetes Care
      • Public Sector
      • Private Sector
  • B. Market Analytics
    • Table 118: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 119: Asia-Pacific Historic Review for Glucose Monitoring Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 120: Asia-Pacific 14-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 121: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 122: Asia-Pacific Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 123: Asia-Pacific 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • China: A Market with Huge Untapped Potential for Glucose Monitoring Devices
    • Table 124: Leading Companies in the Chinese Glucose Meter Market (2017E): Percentage Share Breakdown of Revenue for Abbott, Ascensia, J&J, Omron, Roche, Sinocare & Yuyue (includes corresponding Graph/Chart)
      • Reimbursement of Glucose Monitoring Devices in China (2015): Glucose Meters and Test Strips' Reimbursement Status and Percentage
    • Increasing Diabetes Incidence Remains an Important Growth Driver
    • Table 125: Diabetes Statistics in China (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Key Opportunity Indicator: Aging Population
    • Table 126: Aging Population in China (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 127: Chinese Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 128: Chinese Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 129: Chinese 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Diabetic Epidemic in the Country Drives Strong Demand for Glucose Monitoring Devices
    • Table 130: Diabetes Statistics in India (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s)
    • Growth Stimulants & Challenges in a Nutshell
    • Most Glucose Meters in Indian Market Feature Imported Technology
    • ICMR Develops New Indigenous, Low-Cost Diabetes Detection Technology
    • Market Restraints
  • B. Market Analytics
    • Table 131: Indian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 132: Indian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 133: Indian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Surging Number of Aging Individuals and Diabetic Patients Drive Market Adoption
    • Table 134: Aging Population in Rest of Asia by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Australia: A Growing Market for Glucose Monitoring Devices
    • Table 135: Diabetes Population in Australia (2015): Percentage Share Breakdown of Number of Diabetics by Age Group (includes corresponding Graph/Chart)
    • Table 136: Diabetes Statistics in Australia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in '000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in '000s), and No. of Children with Type 1 diabetes (in '000s) (includes corresponding Graph/Chart)
    • Product Launch
    • Strategic Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 138: Rest of Asia-Pacific Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 139: Rest of Asia-Pacific 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Diabetes in Latin America: Key Statistics
    • Table 140: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 141: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Key Opportunity Indicator: Aging Population
    • Table 142: Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 143: Aging Population in Latin America by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 144: Latin American Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 145: Latin American Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 146: Latin American 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Diabetes Statistics in Africa and the Middle East
    • Table 147: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 148: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Table 149: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)
    • Table 150: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)
    • Key Opportunity Indicator: Aging Population
    • Table 151: Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
    • Table 152: Aging Population in Africa by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 153: Rest of World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 154: Rest of World Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 155: Rest of World 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

  • Total Companies Profiled: 77 (including Divisions/Subsidiaries - 89) The United States (38) Canada (2) Japan (5) Europe (24) - France (1) - Germany (4) - The United Kingdom (6) - Italy (1) - Rest of Europe (12) Asia-Pacific (Excluding Japan) (18) Middle East (1) Latin America (1) GLUCOSE MONITORING DEVICES MCP-3420 CONTENTS
Back to Top